Business strategy in new high‐tech ventures: an empirical analysis

The aim of this study is to determine the existence of specific and unique features characterising markets, activities and customers in at least two of the most representative high technology sectors nowadays, the microelectronics/software industry and the biotechnology/biomedical industry. Cross‐Tabs statistical method has been used to analyze the data collected from the sample made up by 18 high‐tech American firms. One of the major findings of this study is that the business strategy will hold better prospects in those high‐tech firms benefiting from a higher technological excellence, having spent longer time in developing and launching their products, being able to keep longer the novelty attached to their products, being positioned in intermediate to final stages of the production chain.